FONT-SIZE Plus   Neg

Cesca Therapeutics Prices Public Offering At $1.50 Per Unit

Cesca Therapeutics Inc. (KOOL), an autologous cell-based regenerative medicine company, announced that it priced an underwritten public offering of 7.53 million Units, consisting of an aggregate of 7.53 million shares of the Company's common stock and warrants to purchase 2.26 million shares of the Company's common stock, at a price of $1.50 per Unit.

Each warrant entitles the holder to purchase 0.30 of a share of common stock. The warrants will be exercisable immediately upon issuance at an exercise price of $1.55 per share and will expire five years from the date of issuance.

The shares of common stock and warrants comprising the Units are immediately separable. All of the Units in the offering are being sold by Cesca.

The gross proceeds to Cesca from this offering are expected to be approximately $11.3 million, excluding any future proceeds from the potential exercise of the warrants and before deducting underwriting discounts and commissions and other estimated offering expenses payable by Cesca.

The offering is expected to close on or about June 18, 2014, subject to the satisfaction of customary closing conditions.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Follow RTT